Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CE-224535

Copy Product Info
😃Good
Catalog No. T14920Cas No. 724424-43-5
Alias PF-04905428

CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.

CE-224535

CE-224535

Copy Product Info
😃Good
Purity: 99.68%
Catalog No. T14920Alias PF-04905428Cas No. 724424-43-5
CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$118In StockIn Stock
5 mg$297In StockIn Stock
10 mg$419In StockIn Stock
25 mg$679In StockIn Stock
50 mg$953In StockIn Stock
100 mg$1,280In StockIn Stock
200 mg$1,730-In Stock
1 mL x 10 mM (in DMSO)$247In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.68%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.
In vitro
CE-224535 reduces leukocyte secretion of IL-1 and IL-18, thereby providing a novel therapeutic approach for the treatment of rheumatoid arthritis[1].
In vivo
In rats, CE-224535 exhibits a low CLp (11 mL/min/kg) and a large Vdss (7.6 L/kg), resulting in a half-life of 2.4 hours. Oral administration of CE-224535 (5 mg/kg) produces Cmax levels approximately 90 times higher than its IC90 in human blood (0.21 μg/mL or 0.44 μM)[2].
SynonymsPF-04905428
Chemical Properties
Molecular Weight480.94
FormulaC22H29ClN4O6
Cas No.724424-43-5
SmilesCOC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(c2)C(=O)NCC2(O)CCCCCC2)c1=O
Relative Density.1.47g/cm3
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 95 mg/mL (197.53 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (20.79 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0793 mL10.3963 mL20.7926 mL103.9631 mL
5 mM0.4159 mL2.0793 mL4.1585 mL20.7926 mL
10 mM0.2079 mL1.0396 mL2.0793 mL10.3963 mL
20 mM0.1040 mL0.5198 mL1.0396 mL5.1982 mL
50 mM0.0416 mL0.2079 mL0.4159 mL2.0793 mL
100 mM0.0208 mL0.1040 mL0.2079 mL1.0396 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CE-224535 | purchase CE-224535 | CE-224535 cost | order CE-224535 | CE-224535 chemical structure | CE-224535 in vivo | CE-224535 in vitro | CE-224535 formula | CE-224535 molecular weight